ICU Medical Q4: revenue $540.7M (-14% YoY), GAAP loss $(0.64)/share, adj EPS $1.91

ICU MEDICAL INC/DE

2025-FY EPS reported $0.03 revenue$2,231,262,000

Revenue $540.7M vs $629.8M in Q4 2024, down 14.1% YoY.
GAAP net loss $(15.7)M, or $(0.64) per diluted share, improving from $(23.8)M loss in Q4 2024.
Adjusted diluted EPS $1.91, down from $2.11; Adjusted EBITDA $98.2M vs $105.5M.
GAAP gross margin improved to 38% from 36%.
Fiscal 2026 guidance provided but numerical details not included in filing excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.